Navigation Links
Verus Pharmaceuticals Announces Promotion of Robert W. Keith to Chief Executive Officer
Date:11/12/2007

SAN DIEGO, Nov. 12 /PRNewswire/ -- Verus Pharmaceuticals, Inc., a pediatric-oriented specialty pharmaceutical company, announced today that Robert W. Keith has been promoted to President & Chief Executive Officer. Prior to the promotion, Mr. Keith served as President & Chief Operating Officer. As a result of the promotion, Cam L. Garner now will serve exclusively as Executive Chairman.

"We are excited to announce this well-deserved promotion," said Cam L. Garner. "As a co-founder of Verus, Bob has played a critical role in the development and evolution of the company from day one to the present, including our recently announced transaction with AstraZeneca."

"I am honored to take the reins from Cam at this point in time and lead the company forward as we continue to build value in our commercial franchise and accelerate our efforts on our emerging development programs," said Robert W. Keith.

The composition of the Board of Directors will not change with the promotion of Mr. Keith. In addition to Mr. Garner and Mr. Keith, the other current members include James C. Blair, Alex E. Barkas, Jean-Pierre Naegeli, Nicholas J. Simon, David F. Hale, and Erle T. Mast.

About Verus

Verus Pharmaceuticals is dedicated to improving the lives of children and those who care for them. Verus is building a portfolio of products for the unmet medical needs of children through acquisitions and alliances, with an initial focus on the treatment of asthma, allergies, and related diseases and conditions. Verus is differentiated by its pediatric orientation and its strong financial position and experienced management team, which allows the company to capitalize on an extensive network to build its product portfolio and pursue complementary transactions. The company's rigorous, disciplined approach to strategic decision-making and core competencies in development and commercialization is expected to provide significant value to its partners. More information
'/>"/>

SOURCE Verus Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Verus Pharmaceuticals Announces Divestiture of Pediatric Asthma Development Programs to AstraZeneca
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... A US Airman, fresh from basic training ...eukemia patient whose life he saved by donating hi...an Air Base, Republic of Korea (PRWEB) November 21...irman whose blood donation saved her life, met for...ov. 21, 2008. , , , , ,Airman Tamarias Pope, 8th ...
(Date:11/21/2008)..., Fla. -- A Florida State University College of Me...overed an important new layer of regulation in the...r understanding of the way cancer begins. , Wang... the College of Medicine, said the findings will l...could lead to the design of new drugs that kill ca...
(Date:11/21/2008)... Nov. 21 The Generic,P...owing statement today from,GPhA President and CEO...ssion,(FTC) roundtable on "Emerging Health Care C...e fact that the FTC is conducting this roundtable ... that consumers have access to safe and,affordabl...
(Date:11/21/2008)...a., Nov. 21 New researc...er a smokeless, spitless tobacco product aimed at ...ave found that RJ Reynolds, Camel Snus - touted as...contains surprisingly high levels of nicotine. , ...st other snuff products," said Bruce Adkins of the...
Breaking Medicine News(10 mins):Health News:Life-Saving Airman, Leukemia Patient Meet for First Time 2Health News:Life-Saving Airman, Leukemia Patient Meet for First Time 3Health News:GPhA Statement on FTC Roundtable on Biogenerics 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3
...ave shown inhaled corticosteroids can decrease a p... now say long-term use of ICS therapy is not assoc...teroids are commonly used to treat asthmatics and ...nary disorder. Researchers say these medications a...
... thought of rickets as a disease of the past. New ...blem and prevention should start before birth and ... vitamin D supplementation.// Rickets is a childho...kening of the bones, primarily caused by lack of v...
...ave shown breast cancer patients who receive radia...n and a mastectomy may be more likely to develop c...y not be the case. Researchers from the Fox Chase ...east cancer who underwent a mastectomy, breast rec...
...kidney patients have far more to be concerned abou...ciation-sponsored study shows //people with chroni... heart disease. Doctors say the most surprising fi...ople who are in the very early stages of kidney di...
Other Medicine News:
(Date:11/20/2008)...ember 20 The Scandinavian-based dr...ced results of studies on its,lead antimicrobial ...n, DC,the studies showed that the novel lytic pe...ect, significantly better towards killing Staphylo...keted gold standard drugs. In,addition to this it...
(Date:11/19/2008).... 19 Biotech scientists increasing...y research to better understand the effects of nov...reports Genetic Engineering & Biotechnology N...guring out a new compound,s mechanism of action an...chnique, according to the November 15 issue of GE...
(Date:11/18/2008)...PRNewswire/ -- Arlington Medical Resources (AMR), ... pharmaceutical and diagnostic,imaging industries...vigen was,sold in the U.S. during the third quart...venous immune globulin (IVIG) and was launched in ...ted from the blood plasma of thousands,of donors ...
(Date:11/13/2008)...Nutritional Supplements Prior to Surgery, ARLINGT...-- Identifying,malnutrition before surgery in mass...ill significantly decrease surgical complications,...d boost patient energy levels,according to a stud...ive,Surgery(R), the official medical journal of th...
Breaking Medicine Technology:Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2Plastic Surgeons Warn of Malnutrition in Body Contouring Patients 2Newt Gingrich Statement on the Loss of Tony Snow 23855 1Newt Gingrich Statement on the Loss of Tony Snow 23855 2Summer Is Peak Time for Lightning Strikes 23851 1Summer Is Peak Time for Lightning Strikes 23851 2Dramatic increase in Tommy John surgery in young patients cause for concern 23847 1Dramatic increase in Tommy John surgery in young patients cause for concern 23847 2Bioheart Inc Announces Management Change 6516 1Bioheart Inc Announces Management Change 6516 2Bioheart Inc Announces Management Change 6516 3
..., May 21, 2007 - Results from phase III,clinical t...presented at the 16th Congress of the European Aca...data highlighted the,efficacy and safety profile o...tment for patients with severe refractory chronic,...ists for severe Chronic Hand,Eczema (CHE) refracto...
...INESS WIRE)--May 21, 2007 - Gilead Sciences,Inc. ...term studies,evaluating ambrisentan, an investigat... treatment of patients with pulmonary,arterial hyp...ients,who originally participated in the two pivot... study of patients who had,previously discontinued...
Other Medicine Technology:Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 2Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 3Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 4Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 5Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 2Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 3Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 4Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 5Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 6
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
Medicine Products: